Allergies: Symptoms, Causes, Treatment & Nursing Care

Allergic disease reflects inappropriate immune recognition of innocuous antigens. In classic type I hypersensitivity, allergen cross-links IgE bound to FcεRI on mast cells and basophils, releasing histamine, tryptase, leukotrienes, prostaglandins, and cytokines that produce vasodilation, mucus hypersecretion, pruritus, and smooth-muscle bronchoconstriction within minutes. Tissue-resident mast cells in skin, airway mucosa, and gut explain why the same biochemical event can present as erythematous wheals, status asthmaticus–like bronchospasm, or projectile vomiting depending on route and dose of exposure.

Clinicians also encounter mixed or evolving phenotypes: chronic spontaneous urticaria may behave like allergy symptomatically yet lack a clear external trigger; allergen-specific immunotherapy modifies the immune response over months; biologic agents now interrupt IgE or cytokine signaling in selected refractory cases. Ward and clinic nurses anchor safety by distinguishing nuisance symptoms from multisystem reactions, keeping medication and exposure histories granular, and knowing when rapid escalation outpaces oral therapy.

The Gell and Coombs classification still orients teaching even when modern molecular immunology adds nuance. The table below links mechanism to examples you will chart or counsel about—not a substitute for allergist judgement, but a shared language across nursing, pharmacy, and acute teams.

↔On a small screen, swipe or scroll sideways to see the full table.

Allergic presentations range from isolated seasonal sneezing to explosive multisystem collapse. Clustering symptoms by organ clarifies triage and documentation.

Typical patterns

• Skin-mucosa: pruritus, flushing, migratory wheals meeting urticarial morphology, periorbital or mucosal edema.
• Respiratory: sneeze–rhinorrhoea cluster, chest tightness with expiratory wheeze—overlap with asthma requires bronchodilator readiness.
• Gastrointestinal: cramping, vomiting, diarrhoea shortly after ingestion in IgE food reactions.
• Cardiovascular: presyncope, tachycardia out of proportion to anxiety, narrow pulse pressure when distributive shock supervenes.

Atypical or high-risk cues

• Isolated gastrointestinal hypermotility without urticaria can still represent anaphylaxis—especially in children and with certain foods.
• Exercise-induced anaphylaxis when combined with cofactors (NSAID, specific meal) may present only after exertion begins.
• Sedating antihistamines may mask cutaneous warning signs in monitored settings—still treat the hemodynamic picture.

Triggers map to environmental proteins, Hymenoptera venoms, medications, and foods. Atopic inheritance raises IgE responsiveness; defective skin barrier states such as flaring eczema increase sensitization through epicutaneous antigen presentation.

Modifiable or contextual factors

• Viral illness or uncontrolled asthma lowering reaction thresholds during allergen challenges.
• Alcohol or exercise lowering the “eliciting dose” for food-induced reactions in susceptible individuals.
• Occupational exposures (latex in procedural settings, laboratory animal proteins) when PPE or engineering controls slip.

Non-modifiable contributors

• Family history of atopy or prior severe reactions.
• Co-existent mast-cell disorders (consider when flushing, osteoporosis, and episodic hypotension cluster).
• Fixed drug structures (β-lactams, neuromuscular blockers, NSAIDs) with reproducible immune recognition patterns.

Clinical assessment

Record the exact ingredient or generic drug name, timing from exposure to symptom nadir, involved organ systems, prior similar episodes, and autoinjector use. Measure heart rate and blood pressure serially during evolving reactions; inspect skin under adequate lighting—urticaria can be subtle on pigmented skin. Track peripheral and mucosal edema progression.

Laboratory investigations

• Serum tryptase timing (baseline and serial when available) supports retrospective diagnosis in some anaphylaxis presentations but may be normal early—never delays treatment.
• Allergen-specific IgE (immunoassay) or skin-prick testing—specialist-directed—confirms sensitization; negative testing in the context of clear history may still warrant supervised challenge.
• Eosinophilia, while nonspecific, can accompany asthma–rhinitis overlap; interpret alongside presentation.

Imaging

Routine imaging is not first-line; CXR or soft-tissue imaging follows atypical airway obstruction, foreign body concern, or complication evaluation per physician direction.

Criteria and scoring used in practice

Emergency and allergy specialists apply clinical anaphylaxis criteria emphasizing rapid onset involving skin-mucosa plus respiratory or cardiovascular compromise—or sudden hypotension after a known allergen—rather than relying on any single numeric score.

↔On a small screen, swipe or scroll sideways to see the full table.

First-line management

• Acute anaphylaxis: intramuscular adrenaline (epinephrine) in the mid–outer thigh, repeated per guideline cadence, supine positioning with leg elevation if tolerated, high-flow oxygen, IV access—follow local emergency algorithms.
• Adjuncts (ordered): nebulized albuterol for bronchospasm; H1/H2 blockers and hydrocortisone or prednisone do not replace first-line pressor therapy.
• Chronic allergic rhinitis: intranasal corticosteroids as cornerstone; add oral non-sedating antihistamines for breakthrough symptoms.
• Asthma overlap: inhaled corticosteroid–formoterol maintenance and action plans; leukotriene modifier montelukast may help selected nasal–lower airway synergy but monitor neuropsychiatric adverse-effect reporting locally.

Second-line / specialist-directed

• Subcutaneous or sublingual immunotherapy for venom or aeroallergen indication after risk stratification.
• Oral immunotherapy programmes for food allergens under controlled protocols with rescue plans.
• Omalizumab or other biologics for refractory chronic urticaria or severe asthma phenotypes meeting payer criteria.

Special populations

• Children: weight-based adrenaline dosing; caregivers must train on autoinjector technique via subcutaneous injection principles adapted to device-specific instructions.
• Pregnancy: untreated anaphylaxis threatens fetus more than appropriately dosed adrenaline—coordinate obstetric monitoring after stabilization.
• Renal/hepatic impairment: sedating antihistamines accumulate—prefer second-generation agents and pharmacist review.

• Monitoring cadence: after autoinjector administration, repeat vital signs at intervals aligned with your emergency protocol—often every 5–15 minutes until stable, then stretch intervals while watching for biphasic recurrence for many hours.
• Treatment failure: persistent hypotension or rising airway resistance after two appropriate adrenaline doses mandates critical-care escalation and adjunct vasopressors per physician orders.
• Referral urgency: same-week allergy-immunology for new systemic drug or venom reactions; routine queue for stable seasonal rhinitis needing immunotherapy discussion.
• Documentation: capture allergen, route, exact generic drug name, reaction phenotype, auto-injector lot/time if known, and education provided—structured notes speed future operative and antibiotic decision-making.
• MDT roles: pharmacy validates adrenaline concentration strips and IV compatibility; asthma educators align inhaler technique when allergic rhinitis and lower-airway disease coexist.

Clinical decision flow (shift-ready)

1. Exposure + multisystem symptoms? Give IM adrenaline, call resuscitation team, prepare second dose.
2. Skin-only urticaria, stable vitals? Oral H1 blockade per protocol, observe, reassess airway.
3. New drug exposure with delayed rash days later? Suspect type IV pattern—isolate culprit, consult, avoid re-exposure pending review.
4. Discharge after reaction? Supply two autoinjectors where indicated, teach when to reinject, and document observation window met.

Bedside monitoring checklist

• Continuous pulse oximetry when any respiratory involvement.
• Two large-bore IV lines when planning fluid boluses or second-line pressors.
• Glucose in children after adrenaline—track tremor versus hypoglycaemia confusion.

• Hypoxic brain injury or cardiac arrest from prolonged untreated shock.
• Secondary aspiration if vomiting during obtundation—positioning and suction readiness matter.
• Traumatic injury if patient collapses during syncopal phase—pad bed rails only where policy permits but prioritize resuscitation.
• Chronic disease burden from poorly controlled allergic rhinitis (sleep debt, exam underperformance) or brittle asthma.

Clinician-facing prevention emphasizes accurate allergen avoidance plans, timely immunotherapy when indicated, environmental controls for dust mite or pet dander in sensitized patients, smoking cessation to repair epithelial integrity, and influenza vaccination per local guidance in asthma cohorts—not because the vaccine treats allergy, but because respiratory infections destabilize reactive airways.

Many children tolerate previously allergenic foods over time under specialist supervision; aeroallergen sensitivities more often persist. Prognosis after anaphylaxis hinges on trigger avoidance literacy, reliable autoinjector access, and asthma control—patients with dual food allergy and poorly controlled asthma remain in higher residual risk strata.

Medication safety

Verify adrenaline ampoule concentration (1 mg/mL vs 0.1 mg/mL paediatric dilution) before drawing—sound-alike errors occur under stress. Chart whether antihistamines were sedating to inform observation levels.

Communication

Use teach-back for autoinjector steps and review allergy action plans in the patient’s first language where possible; photo documentation of rashes (with consent) helps outpatient allergy services.

Escalation triggers

• Stridor, inability to complete sentences, or silent chest after presumed treatment.
• Systolic blood pressure falling despite fluids and repeated adrenaline.
• Altered consciousness or repeated vomiting in a paediatric patient post-reaction.

These NCLEX-style clinical judgment practice items focus on the nursing priorities for this condition — recognise cues, escalate red flags, take safe action and evaluate outcomes (NCSBN Clinical Judgment Measurement Model) — through Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response, matrix matching and cloze drops on the topic of IgE-mediated allergy spectrum, anaphylaxis recognition / IM adrenaline, biphasic reactions, allergy testing pathways and avoidance / immunotherapy planning.